Track the ORYZON GENOMICS, S.A. share price and the full insider trade history of the company, a publicly traded company based in Spain. Shares are quoted on ES ES, under the supervision of CNMV. Operating in the Health Care sector, ORYZON GENOMICS, S.A. has logged 0 reports. Market capitalisation: €235.7m. Every trade is free.
Analysts rate ORYZON GENOMICS, S.A. Strong Buy (bullish), based on 3 analysts. Average price target: €7.13.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
0 of 0 declarations
ORYZON GENOMICS, S.A. is a company focused on the research and development of innovative treatments based on genomics. It is listed on the XMAD market.